Back to Search
Start Over
Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
- Source :
-
Journal of ethnopharmacology [J Ethnopharmacol] 2015 Dec 24; Vol. 176, pp. 336-44. Date of Electronic Publication: 2015 Nov 23. - Publication Year :
- 2015
-
Abstract
- Ethnopharmacological Relevance: The modified-Chungsimyeolda-tang (DG) is an important traditional Korean herbal formula used in traditional oriental medicine for treatment of cerebrovascular disorders, including stroke. The formula is based on the book "Dongui Sasang Shinpyun".<br />Aim of the Study: In the previous studies, the neuroprotective effect of DG is demonstrated in an in vitro Parkinson's disease (PD) model, and in this study, the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) animal model of PD is used to evaluate the behavioral effect of DG and possible mechanism through anti-apoptosis of DG. 6-Hydroxydopamine (6-OHDA) also is used to evaluate the anti-apoptosis effect of DG in SH-SY5Y cells.<br />Materials and Methods: MPTP was used to evaluate the behavioral damage and neurotoxicity in mice. The bradykinesia symptom was measured by a Pole test and a Rota-rod test in mice. Also the loss of tyrosine hydroxylase (TH)-positive neurons induced by MPTP was examined by an immunohistochemical assay. The DG-mediated anti-apoptosis effect was measured using an immunoblotting assay with apoptosis-related markers such as Bax and cleaved caspase-3. DG and 1-methyl-4-phenylpyridinium (MPP(+)) were co-treated with primary dopaminergic neurons to evaluate the protective effect of DG. The expression of caspase-3 and PARP was measured to detect the protective effect of DG from the damage by 6-OHDA.<br />Results and Conclusions: The treatment with DG resulted in prophylactic effects on MPTP-induced Parkinsonian bradykinesia and the immunohistochemical analysis showed that DG provided the neuroprotection against the MPP(+)-induced dopaminergic neurons loss through the anti-apoptosis effect. The present results suggested that it might be possible to use DG for the prevention of substantia nigra pars compacta (SNpc) degeneration induced by exposure to the toxic substances, such as MPTP/MPP(+), in PD mouse model.<br /> (Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.)
- Subjects :
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Antiparkinson Agents pharmacology
Apoptosis drug effects
Behavior, Animal drug effects
Brain cytology
Brain drug effects
Brain metabolism
Caspase 3 metabolism
Cell Death drug effects
Cell Line, Tumor
Cells, Cultured
Disease Models, Animal
Dopaminergic Neurons drug effects
Humans
Korea
Male
Medicine, Traditional
Mice, Inbred C57BL
Neuroprotective Agents pharmacology
Neurotoxins
Parkinson Disease metabolism
Phytotherapy
Plant Extracts pharmacology
Rats, Sprague-Dawley
bcl-2-Associated X Protein metabolism
Antiparkinson Agents therapeutic use
Neuroprotective Agents therapeutic use
Parkinson Disease drug therapy
Plant Extracts therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1872-7573
- Volume :
- 176
- Database :
- MEDLINE
- Journal :
- Journal of ethnopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 26593210
- Full Text :
- https://doi.org/10.1016/j.jep.2015.11.013